Related Experiment Video
Updated: Feb 17, 2026
08:35
Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
8.4K
E2F1 interacts with BCL-xL and regulates its subcellular localization dynamics to trigger cell death.
Céline Vuillier1, Steven Lohard1, Aurélie Fétiveau1
1CRCINA, INSERM, U1232, Université de Nantes, Nantes, France.
EMBO Reports
|December 14, 2017
Summary
The transcription factor E2F1, a key player in tumor suppression, also triggers cell death by localizing to mitochondria. It stabilizes BCL-xL at mitochondrial membranes, promoting cell death.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- The pRB-regulated tumor suppressor pathway utilizes E2F1 as a primary effector.
- E2F1 promotes transcription of pro-apoptotic proteins, contributing to cell death.
- Understanding E2F1's role in apoptosis is crucial for cancer therapy.
Purpose of the Study:
- To investigate the role of E2F1 in apoptosis beyond its transcriptional function.
- To determine if E2F1 has a direct role in mitochondrial-mediated cell death.
- To elucidate the mechanism by which E2F1 influences BCL-xL activity.
Main Methods:
- Mitochondrial localization studies of E2F1.
- Analysis of E2F1-BCL-xL interactions.
- Assessment of mitochondrial outer membrane permeabilization.
- Investigation of BAK regulation by E2F1-BCL-xL complex.
Main Results:
- E2F1 was found to partly localize to mitochondria.
- E2F1 interacts with BCL-xL at mitochondrial membranes, independent of the BH3-binding interface.
- E2F1 binding stabilizes BCL-xL at the mitochondrial membrane.
- This stabilization disrupts BCL-xL's control over binding partners like BAK, inducing apoptosis.
Conclusions:
- E2F1 acts as a novel regulator of BCL-xL localization and function.
- E2F1's mitochondrial localization and interaction with BCL-xL represent a new mechanism of apoptosis induction.
- This finding offers potential new therapeutic targets in cancer treatment.
More Related Videos
13:54Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
Published on: October 21, 2012
11.4K
07:17Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex
Published on: August 2, 2021
3.0K
Related Concept Videos
01:31The Intrinsic Apoptotic Pathway
8.7K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.7K
01:17The Extrinsic Apoptotic Pathway
8.8K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.8K
01:23Negative Regulator Molecules
38.6K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K
01:30Overview of Cell Death
10.3K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
10.3K
02:23Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
01:15Receptor Downregulation in MVBs
2.9K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.9K